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PURPOSE. To evaluate the levels of dinucleotides diadenosine
tetraphosphate (Ap4A) and diadenosine pentaphosphate
(Ap5A) in tears of patients wearing rigid gas permeable
(RGP) contact lenses on a daily wear basis and of patients
wearing reverse-geometry RGP lenses overnight for orthokera-
tology treatment.
METHODS. Twenty-two young volunteers (10 females, 12 males;
23.47 6 4.49 years) were fitted with an alignment-fit RGP lens
(paflufocon B) for a month, and after a 15-day washout period
they were fitted with reverse-geometry RGP lenses for corneal
reshaping (paflufocon D) for another month. During each
period, tears were collected at baseline day 1, 7, 15, and 28.
Ap4A and Ap5A were measured by high-pressure liquid
chromatography (HPLC). Additionally, corneal staining, break-
up time (BUT), Schirmer test, and dryness symptoms were
evaluated.
RESULTS. Ap4A concentrations increased significantly from
baseline during the whole period of daily wear of RGP lenses
(P < 0.001); concentration was also significantly higher than in
the orthokeratology group, which remained at baseline levels
during the study period except at day 1 (P < 0.001) and day 28
(P ¼ 0.041). While BUT and Schirmer remained unchanged in
both groups, discomfort and dryness were significantly
increased during alignment-fit RGP daily wear but not during
the orthokeratology period.
CONCLUSIONS. Daily wear of RGP lenses increased the levels of
Ap4A due to mechanical stimulation by blinking of the corneal
epithelium, and this is associated with discomfort. Also,
orthokeratology did not produce symptoms or signs of ocular
dryness, which could be a potential advantage over soft
contact lenses in terms of contact lens-induced dryness.
(Invest Ophthalmol Vis Sci. 2012;53:4426–4432) DOI:
10.1167/iovs.11-9342
Wearing contact lenses (CL) is one factor that can disturbtear dynamics, potentially resulting in ocular discomfort,
dryness, and ocular surface disease.1–4 CL-related comfort
issues might involve a wide range of factors, which are
particularly active under certain environmental conditions.5
More than half of CL wearers self-report dry eye symptoms.1
Some of these wearers reduce their lens wear time and some
eventually abandon lens wear. Over 15% of lens wear dropout
is attributed to dryness, and nearly 30% to ocular discomfort.6,7
Regarding rigid gas permeable lenses (RGP), it is commonly
accepted that initial comfort will be low, increasing during the
first few days until regular use during the whole day.8 A unique
case within the RGP field is overnight orthokeratology for
corneal reshaping or corneal refractive therapy (CRT).
Clinicians are aware that the eyelids play a major role in RGP,
CL-related discomfort during blinking, and this is common at
first and within the adaptation period of all RGP lenses. This
inconvenience is minimized in CRT9 because the lenses are
worn overnight with no blinking interactions.
The Dry Eye Workshop proposed to diagnose dry eye by
combining different tests to identify signs and symptoms.10
However, it is necessary to be aware that the diagnosis of dry
eye is difficult due to the poor correlation between dry eye
signs and symptoms.11 Analytical techniques are providing
valuable information about new components in tears that may
have important biochemical and physiological functions.12
Among these tear components, diadenosine polyphosphates
emerge as interesting compounds. They are released in the tear
film by corneal shear stress during blinking, inducing an
increase of dinucleotide concentration,13 and have important
intracellular and extracellular physiological actions. It is known
that Ap4A and Ap5A concentrations increase in patients with
dry eye symptoms and Sjo¨gren syndrome, suggesting the
possibility of these compounds being used as objective
markers to diagnose and classify dry eye.13,14 Moreover, a
single-dose topical application of the dinucleotide Ap4A in
rabbits has demonstrated to stimulate tear secretion, which
confers to these compounds a secretagogue action.15 Ap4A
also has the ability to accelerate corneal wound healing in New
Zealand white rabbits.16
Due to the involvement of diadenosine polyphosphates in
the ocular surface physiopathology and its release mechanism
related with blinking, it is a matter of interest to investigate a
possible relationship between the concentrations of these
substances and the development of dry eye in CL wearers—in
this case, RGP lenses with different wearing schedules. With
the aim of examining this relationship, the present work
described variations in the levels of diadenosine polyphos-
phates (Ap4A and Ap5A) during 1 month with alignment-fit
aspheric RGP lenses worn on a daily basis, followed by a
washout period of 2 weeks, and finally another month with
reverse geometry for CRT worn overnight. Furthermore, study
authors examined tear volume and stability, corneal staining,
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and discomfort and dryness symptoms, which may be present
during dry eye.
METHODS
Twenty-two patients (12 males and 10 females) with ages ranging from
19 to 36 years (average 23.47 6 4.49 years) were recruited from the
student population at the Clinical & Experimental Optometry Research
Lab (University of Minho, Braga, Portugal). The study was conducted in
compliance with good clinical practice guidelines, informed consent
regulations, and the tenets of the Declaration of Helsinki. All of the
subjects enrolled in the study were adults older than 18 years who
were able to give informed consent. More detailed demographic
characteristics of the population are shown in Table 1. After the
purpose of the study was explained and all doubts clarified to the
participants, a consent form was presented and signed by both the
patient and the researcher.
Fitted lenses were made of high oxygen permeability materials
(paflufocon D for CRT and paflufocon B for RGP lenses). Technical
parameters of the lenses are shown in Table 2.
Patients underwent a complete preliminary optometric examina-
tion including objective and subjective refraction, using the maximum
plus for better visual acuity as endpoint criterion. Ocular surface
inspection included slit-lamp examination and keratometry. The lenses
were fitted in conformity with the manufacturers’ recommendations.
When lenses were prescribed, instructions about wearing schedule,
insertion, removal, and care recommendations were given to the
patient. The care system consisted of a multipurpose solution for RGP
lenses (Boston Simplus; Bausch & Lomb, Rochester, NY). During
orthokeratology lens wear, patients were instructed to apply rewetting
drops (Moisture Eyes; Bausch & Lomb) at insertion in the evening and
before removal of their lenses in the morning.
Trials
Aftercare visits were scheduled at days 1, 7, 15, and 28. Tear analysis,
corneal staining, and recording of subjective symptoms including
dryness and discomfort using the Dry Eye Questionnaire (DEQ) were
carried out during these visits.17,18
Tear secretion was measured using the Schirmer I test (without
anesthesia). Tear collection was always performed following Van
Bijsterveld criteria.19 The Schirmer strip (Tear Flo; HUB Pharmaceuti-
cals, Rancho Cucamonga, CA) was placed on the temporal tarsal
conjunctiva of the lower lid for 5 minutes with the eyes closed. The
volume of tears was recorded as millimeters of moistened strip, and the
wetted ends of the Schirmer strip were placed in Eppendorf tubes
containing 500 lL of ultrapure water. The samples were then frozen
until the high-pressure liquid chromatography (HPLC) analysis was
performed.13 Tear collection during RGP daily wear regimen was
performed in the evening after using lenses with 15 minutes of
washout. In the case of orthokeratology, the Schirmer test was
performed in the morning after removing the lenses and with the same
time of washout.
After the Schirmer I test, fluorescein was applied to evaluate BUT
and corneal staining. In order to warrant repeatability of the staining
procedure, a solution was prepared using a 10% concentration of
sodium fluorescein diluted in saline (NaCl 0.9%). For each application,
a micropipette with 5 lL of diluted fluorescein solution was applied in
the inferior conjunctival sac and 20 seconds later, BUT was analyzed
using a chronograph to record the tear film break-up time after the
patient was asked to blink twice and remain with the eyes open. The
cornea was divided in five areas to record the grading staining as
proposed by the Report of the National Eye Institute and Industry-
Sponsored Dry Eye Workshop,20 using the Cornea and Contact Lens
Research Unit grading scales.21
The patients were asked to characterize the frequency of two main
symptoms of dry eye—namely, discomfort and dryness—which appear
on the DEQ, elaborated by Begley et al.17 DEQ was designed to assess
the prevalence, frequency, and diurnal severity of ocular surface
symptoms such as discomfort, dryness, visual changes, soreness,
TABLE 1. Demographic Information of the Population Enrolled in the
Study
Parameter Values
Number of patients 22
Mean age (years 6 SD) 23.47 6 4.49
Age range (years) 19, 36
Sex (male/female) 12, 10
Mean corneal astigmatism (D 6 SD) 0.83 6 0.36
Range of corneal astigmatism (D) 0.10, 1.14
Mean flat keratometry (D) 42.91 6 1.13
Mean steep keratometry (D) 43.74 6 1.36
Mean refractive sphere (D 6 SD) 1.92 6 1.23
Range of refractive sphere (D) 0.25, 5.25
Mean refractive cylinder (D 6 SD) 0.30 6 0.33
Range of refractive cylinder (D) 0, 0.75
All subjects underwent both parts of the study either with the
alignment-fit RGP lens on a daily wear basis or with the reverse-
geometry lens worn overnight.
TABLE 2. Technical Parameters of the Lenses Used in the Study
Parameter Alignment-Fit Aspheric Lens Reverse-Geometry Lens
Manufacturer Lenticon (Madrid, Spain) Paragon Vision Science (Mesa, AZ)
Material (USAN) Paflufocon B Paflufocon D
Brand Oxicon HDS Paragon CRT
Manufacturing process Lathe-cut Lathe-cut
Back surface geometry Central 5 mm: spherical Sigmoid geometry
Periphery: aspheric (ecc. ¼ 0.35)
Front surface geometry Spheric Mirrored with anterior surface
Overall diameter (mm) 9.80 10.50
Optic zone diameter (mm) 9.00 6.00
Center thickness (@3.00 D in mm) 0.180 0.166
Dk (barrer) 58 100
Contact angle 14.8
Hardness (shore) 84
UV filter No No
Powers fitted (D) 0.25 to 6.75 þ0.50
Back optic zone radius (mm) 7.00 to 9.00 7.90 to 8.90
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irritation, grittiness, scratchiness, foreign body sensation, burning, light
sensitivity, and itching. The patients had to choose between four
different frequencies (1¼ rarely; 2¼ sometimes; 3¼ frequently; and 4¼
constantly).
Tear Preparation and HPLC Analysis
After thawing, the samples were strongly vortexed for 5 minutes. The
strips were carefully rinsed, and the liquid in the Eppendorf tube was
heated in a 1008C bath for 20 minutes to precipitate proteins. In order
to pellet the proteins, the tubes were centrifuged at 4000 rpm for 30
minutes. Diadenosine polyphosphates are not degraded by this
treatment as previously demonstrated.22 Supernatants were chromato-
graphed through sample preparation cartridges (SEP-PAK Accell QMA;
Waters Corp., Milford, MA) as previously described.23 These eluents
were injected at a volume of 10–100 lL.
Determination and quantification of diadenosine polyphosphates
were performed by HPLC. The chromatographic system consisted of an
isocratic pump (Waters 1515 Isocratic HPLC Pump; Waters Corp.), a
dual absorbance detector (Waters 2487 Detector; Waters Corp.) and a
sample injector valve (Rheodyne; Waters Corp.), all managed by HPLC
software (Breeze 2 HPLC; Waters Corp.). The column (Nova-Pak C18;
Waters Corp.) was 15 cm in length, 0.4 cm in diameter. The system was
equilibrated overnight with the following mobile phase: 0.1 M
KH2PO4, 2 mM tetrabutylammonium, 17% acetonitrile, pH 7.5.
16
Detection was monitored at 260-nm wavelength. All the peaks
identified as putative dinucleotides were taken for phosphodiesterase
treatment. Phosphodiesterase from Crotalus adamanteus (EC 3.1.4.1.;
Sigma, St. Louis, MO), at a concentration of 1.0 U/mL, was incubated at
room temperature for 30 minutes with the corresponding putative
dinucleotide. The digestion products were analyzed by HPLC. Peaks
were transformed into concentrations by means of external standards
of known concentrations of diadenosine polyphosphates.
Statistical Analysis
Data were analyzed by statistical software (SPSS version 15.0 for
Windows; SPSS, Inc., Chicago, IL). The values presented are the means
6 SEM of the experiments performed. Parametric tests were used to
compare the study groups. Normality of distribution was assessed
using the Shapiro-Wilk test. Differences between RGP lenses and CRT
groups in tear function test were estimated by the Student’s t-test for
related samples. Study authors also used the Student’s t-test for related
samples to assess the differences among different follow-up visits into
each group. Correlations between increments of Ap4A and tear volume
regarding the preliminary visit were assessed by Pearson bivariate
regression. A value of P < 0.05 was considered statistically significant.
RESULTS
Diadenosine Polyphosphates
Ap4A increased its concentration in tears in both alignment-fit
RGP lenses and CRT in the first day after fitting, increasing 4-
and 2-fold compared with the baseline visit, respectively. After
1 month, Ap4A continued significantly increased with align-
ment-fit lenses (P < 0.001). During CRT lens wear, Ap4A
concentrations returned to baseline levels after 1 week,
although a significant increase was also observed for samples
collected 1 month after fitting (P ¼ 0.041). Despite this, the
values reached were much lower than during alignment-fit
RGP lens wear. Indeed, there were statistically significant
differences between RGP lenses and CRT lenses in Ap4A
concentration in all follow-up visits (P < 0.001; Fig. 1). Ap5A
concentrations remained stable during the study in both
groups, except at week 1 in RGP lenses (P < 0.008), and at
the end of the study in CRT lenses (P < 0.001; Fig. 2, Table 3).
Schirmer I Test, Tear BUT (TBUT), and Corneal
Staining
For alignment-fit RGP lenses, the tear volume increased slightly
but not to a statistically significant level. In contrast, Schirmer
was stable during the study with CRT lenses. BUT was stable
during the study for both lenses (Figs. 3, 4, Table 3).
Corneal staining was similar with both types of lenses,
without differences up to the end of the 1-month period for
the alignment-fit RGP lens wearing. Conversely, significant
differences were found from baseline at 2 weeks and 28 days of
CRT wearing period (P < 0.05). Differences between RGP
lenses and CRT were statistically significant at visit day 28 (P <
0.001; Fig. 5).
Symptoms
Study authors evaluated the frequency of two typical dry eye-
related symptoms such as discomfort and dryness. In the case
of discomfort, it remained significantly increased during the
whole period of the study with alignment-fit RGP lenses (Table
3). With CRT lenses, patients only show a statistically
significant difference at visit day 28 (P¼ 0.049), but the levels
of discomfort were significantly lower with CRT compared
FIGURE 1. Concentrations of Ap4A during 1-month follow-up, with
both RGP lenses and CRT lenses. Ap4A increases its concentration in
tears in alignment-fit RGP lenses throughout the study (P < 0.001). For
CRT lens wear, Ap4A concentrations show an increase in the first day
and at the end of the study (P ¼ 0.041). **P value < 0.05 RGP versus
CRT. Student’s t-test.
FIGURE 2. Concentrations of Ap5A during 1-month follow-up, with
both RGP lenses and CRT lenses. Ap5A concentrations remained stable
during the study in both groups, except at week 1 in RGP lenses (P <
0.008), and at the end of the study in CRT lenses (P < 0.001). *P value
< 0.05 RGP, **P value < 0.01 versus CRT. Student’s t-test.
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TABLE 3. Comparisons between Baseline and Different Follow-Up Visits and between Treatments for Different Variables during the Course of the
Study
Variable Visit RGP
P Value
(against baseline) CRT
P Value
(against baseline)
P Value
(RGP vs. CRT)
Ap4A (lM) mean (SEM) Pre-visit 0.140 (0.015) 0.139 (0.023) 0.971
1 day 0.543 (0.064) <0.001 0.297 (0.039) 0.001 0.002
1 week 0.481 (0.078) <0.001 0.150 (0.027) 0.758 <0.001
2 weeks 0.681 (0.080) <0.001 0.197 (0.127) 0.108 0.002
4 weeks 0.647 (0.092) <0.001 0.224 (0.033) 0.041 <0.001
Ap5A (lM) mean (SEM) Pre-visit 0.053 (0.012) 0.027 (0.004) 0.046
1 day 0.041 (0.014) 0.523 0.031 (0.007) 0.620 0.523
1 week 0.019 (0.002) 0.008 0.029 (0.009) 0.817 0.284
2 weeks 0.024 (0.006) 0.055 0.035 (0.009) 0.367 0.315
4 weeks 0.033 (0.004) 0.161 0.012 (0.001) <0.001 <0.001
Schirmer (mm) mean (SEM) Pre-visit 18.15 (2.30) 15.91 (1.87) 0.454
1 day 21.12 (1.86) 0.320 18.68 (2.33) 0.359 0.418
1 week 19.5 (2.31) 0.662 15.69 (2.10) 0.939 0.229
2 weeks 22.23 (2.08) 0.209 14.88 (2.06) 0.715 0.016
4 weeks 21.80 (2.81) 0.316 14.50 (2.00) 0.610 0.040
BUT (s) mean (SEM) Pre-visit 5.17 (0.28) 6.14 (0.59) 0.145
1 day 4.94 (0.35) 0.607 6.15 (0.50) 0.993 0.054
1 week 5.50 (0.52) 0.545 6.83 (0.58) 0.410 0.095
2 weeks 5.23 (0.59) 0.926 6.41 (0.58) 0.750 0.161
4 weeks 6.40 (0.78) 0.112 6.14 (0.48) 0.990 0.778
Corneal staining mean (SEM) Pre-visit 0.71 (0.12) 0.74 (0.11) 0.855
1 day 0.88 (0.13) 0.333 0.54 (0.12) 0.217 0.061
1 week 0.69 (0.12) 0.898 0.48 (0.11) 0.090 0.204
2 weeks 0.69 (0.12) 0.552 0.42 (0.11) 0.042 0.105
4 weeks 1.0 (0.11) 0.091 0.37 (0.10) 0.016 <0.001
Discomfort mean (SEM) Pre-visit 0.64 (0.09) 0.58 (0.13) 0.706
1 day 2.40 (0.22) <0.001 0.57 (0.15) 0.960 <0.001
1 week 2.66 (0.23) <0.001 0.95 (0.16) 0.078 <0.001
2 weeks 1.77 (0.23) <0.001 0.90 (0.18) 0.159 0.005
4 weeks 1.90 (0.25) <0.001 0.95 (0.13) 0.049 0.002
Dryness mean (SEM) Pre-visit 0.56 (0.12) 0.58 (0.15) 0.918
1 day 1.06 (0.19) 0.029 0.47 (0.13) 0.584 0.014
1 week 1.46 (0.24) 0.002 0.85 (0.14) 0.195 0.034
2 weeks 1.23 (0.23) 0.017 1.00 (0.16) 0.060 0.416
4 weeks 1.50 (0.23) 0.001 1.05 (0.18) 0.050 0.131
Comparison post-wear with pre-wear values
FIGURE 3. Schirmer test without anesthesia during 1-month follow-up,
with both RGP lenses and CRT lenses. For RGP lenses, the tear volume
increased slightly but not to a statistically significant level, and CRT
lenses remained stable during the study. There are statistical
differences between both wear regimens at the end of the study. *P
value < 0.05 RGP versus CRT. Student’s t-test.
FIGURE 4. TBUT during 1-month follow-up, with both RGP lenses and
CRT lenses. There are no differences between both wear regimens or
at follow-up visits.
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with alignment-fit lenses. For dryness, the frequency was
significantly increased during every study visit for alignment-fit
RGP lenses. With CRT lenses, patients showed an increase in
dryness frequency, but this was nonstatistically significant
(Figs. 6, 7). When comparing both lenses, study authors
observed differences only at day 1 and day 7 (P¼0.014 and P¼
0.034, respectively).
Correlations
The Pearson’s correlation coefficient was 0.683 (P¼ 0.029) for
tear volume and Ap4A differences at 15 days of RGP daily wear.
The value of this coefficient indicates a moderate degree of
correlation and the positive sign means that the greater the
result of the Schirmer test, the greater the level of Ap4A. With
respect to the Pearson’s correlation coefficient, both wear
regimens showed a low-to-moderate positive correlation for all
visits (Table 4).
DISCUSSION
Nucleotides and dinucleotides are important tear molecules in
normal and pathological conditions.13,24–26 However, the
possible changes of these substances in patients fitted with
RGP lenses have not yet been investigated. With this aim, study
authors evaluated Ap4A and Ap5A dinucleotide concentrations
before and during 1 month with an alignment-fit RGP lens on a
daily wear basis against reverse geometry CRT lenses worn
overnight.
When the patients wore RGP lenses, there was an increase
in Ap4A levels, whereas Ap5A remained stable. During the CRT
wearing time, there was an increase in Ap4A during the first
day, returning to baseline levels thereafter. Ap5A was stable
throughout the study, and also during the wearing period of
the latter type of lens.
Previous studies showed that the main mechanism of
dinucleotide release in tears is caused by a mechanical stress
on the epithelial cells of the ocular surface. It is also possible
that Ap4A could be released as a consequence of mechanical
corneal nerve stimulation.13
CL wear can induce a shear stress and neural stimulation on
the corneal epithelium by blinking, and therefore, it seems
clear that blinking during RGP lens wear increases the
concentrations of Ap4A.
Peral et al. found that when performing a mechanical
stimulation of the corneal nerve fibers with a Belmonte
esthesiometer with different intensities, Ap4A increases its
concentration but Ap5A remains constant. In contrast, both
Ap4A and Ap5A increase their concentration by mechanical
friction on the epithelium. The fact that Ap5A remains stable
could indicate that part of the dinucleotide release is due to
neural stimulation as a consequence of blinking. While the
levels of Ap4A in the CRT group were similar to the ones
obtained in previous experiments for the 12 blinks per minute
rate,13 this value was higher in the alignment-fit RGP group.
This effect could be explained by the increased mechanical
effect exerted by the RGP lens during the blinking. In the case
of CRT lenses, there was no stimulation by lens friction
because patients wore the lenses on an overnight regimen. A
pilot experiment performed with six volunteers who slept
with alignment-fit RGP lenses showed virtually the same
concentrations in Ap4A to that obtained with the same
individuals with CRT lenses (results not shown), confirming
the effect of blinking in dinucleotides concentrations.
Tear volume was slightly increased when patients wore
alignment-fit RGP lenses, but remained stable with CRT lenses.
It has been demonstrated that dinucleotides can induce tear
secretion,15 and study results showed a positive correlation
between increments of Ap4A and tear volume at follow-up
visits. Therefore, an increase of Ap4A in RGP daily wear
provides more tear volume. No significant differences were
observed in TBUT and corneal staining during RGP and CRT
wear time. However, TBUT was slightly lower and corneal
staining was higher, reaching statistically significant differences
FIGURE 5. Corneal staining grade during 1-month follow-up, with both
RGP lenses and CRT lenses. There are no differences between both
wear regimens. In RGP lens wear, it showed an increase at the end of
the study. **P value < 0.01 RGP versus CRT. Student’s t-test.
FIGURE 6. Discomfort symptom frequency during 1-month follow-up,
with both RGP lenses and CRT lenses. RGP daily wear regimen showed
statistical differences with respect to CRT lenses in all follow-up visits.
**P value < 0.01 RGP versus CRT. Student’s t-test.
FIGURE 7. Dryness symptom frequency during 1-month follow-up,
with both RGP lenses and CRT lenses. RGP daily wear regimen showed
statistical differences with respect to CRT lenses in day 1 and 7 of lens
wearing. *P value < 0.05 RGP versus CRT. Student’s t-test.
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at the end of the study in RGP wear time. This is probably due
to the interaction of the contact lens with the tear film and
blinking, such as an infrequent or partial blinking and/or
thinning of prelens tear film.27,28 Those results match with
previous findings described by other authors.29,30
Discomfort was reported during the whole period of the
study with both lenses. However, patients showed more
discomfort with alignment-fit RGP lenses than with CRT
lenses. One unexpected result is the increase in discomfort
with CRT ‘til the end of the first month, while remaining at a
lower level than with alignment-fit RGP lenses. The blinking
action could explain the discomfort reported by the patients
during the first days of RGP lens daily wear, which was not
experienced with CRT lenses worn overnight. The slight
increase of discomfort with CRT lenses over time could be
related to blinking in the morning during the period between
the patients’ awake and removal of the lenses. Gonza´lez-
Me´ijome et al. demonstrated that in CRT wearers, discomfort
was higher in the morning before removing than at night
before fitting the lenses.9
From the clinical perspective, the paths of slight transient
increase in Ap4A in the CRT group might reflect the initial
discomfort reported by the patients at insertion and removal
during the first days of treatment. Indeed, after the first day of
treatment, the increase in Ap4A follows a similar path in
alignment-fit RGP and CRT groups. This might reflect that the
compression of the epithelium (which will be maximum
during this period) does not increase significantly the
expression of this dinucleotide still remaining at a lower rate
compared with the RGP group.
Despite the growth of orthokeratology in clinical practice
during the past decade, no study has directly addressed the
question of signs and symptoms of dryness in CRT wearers. A
similar situation lacking comparison terms is applicable to
alignment-fit RGP lenses,31,32 because comfort-related ques-
tions have been marginally considered in recent clinical
research, probably because of their minor role in current
fitting strategies. However, there are studies about soft contact
lens wearers and dry eye symptomatology that showed an
increase of dryness and discomfort.5,33,34
The dry eye symptomatic subjects with normal tear
secretion presented similar Ap4A concentrations, which were
found in the present study during RGP wearing time on a daily
wear basis.13 Jansen et al. found that blinking frequency with
contact lens wear rose, while ocular irritation and discomfort
increased during near tasks.35 This suggests that an increase in
discomfort produces a higher frequency of blinking, which
causes the increased release of Ap4A to the tear film in order to
minimize the symptoms. It would be interesting to conduct a
long-term study with successful RGP patients to assess possible
changes in the concentration of Ap4A, once the patients report
comfort rates comparable to soft contact lenses after a period
of 3 to 6 months.8
Present results are significant to better understand the
clinical response of the patient in terms of symptoms and signs
during orthokeratology treatment in comparison with a model
of daily RGP lens wear. Further research must be done in order
to capture the actual effect of CRT over Ap4A expression by
measuring Ap4A levels at different time intervals during the
day, and also for longer periods in the medium and long-term of
the orthokeratology treatment.
In conclusion, daily wear of an alignment-fit RGP lens
increases the levels of Ap4A up to six times over baseline
values, probably due to mechanical stimulation of the corneal
epithelial cells, and this is associated with an increase in the
levels of discomfort and dryness sensation reported by the
patient. These effects might drive an increase in tear volume to
minimize the symptomatology. Conversely, overnight ortho-
keratology lenses only increase Ap4A concentration during the
very initial period of wear, although to a much lower extent
than the alignment-fit lens worn on a daily basis, indicating that
orthokeratology in the short term does not produce symptoms
or signs of ocular dryness.
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